Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XTLB Xtl生物制药

交易中 07-26 14:56:25 EDT

2.98

+0.12

+4.19%

最高2.98	最低2.62	成交量6,806
今开2.97	昨收2.86	日振幅12.58%
总市值1,624万	流通市值1,231万	总股本544.91万
成交额1.96万	换手率0.16%	流通股本413.26万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"XTLB","market":"US","secType":"STK","nameCN":"Xtl生物制药","latestPrice":2.9799,"timestamp":1722019846998,"preClose":2.86,"halted":0,"volume":6806,"delay":0,"floatShares":4132579,"shares":5449061,"eps":-0.0693,"marketStatus":"交易中","marketStatusCode":2,"change":0.1199,"latestTime":"07-26 14:56:25 EDT","open":2.97,"high":2.9799,"low":2.62,"amount":19617.7620902,"amplitude":0.125839,"askPrice":2.97,"askSize":300,"bidPrice":2.92,"bidSize":2650,"shortable":0,"etf":0,"ttmEps":-0.0693,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1722024000000},"adr":0,"adjPreClose":2.86,"adrRate":100,"postHourTrading":{"tag":"盘后","latestPrice":2.86,"preClose":2.86,"latestTime":"19:44 EDT","volume":2,"amount":5.96,"timestamp":1721951057761},"volumeRatio":0.279012},"requestUrl":"/m/hq/s/XTLB/tweets","defaultTab":"tweets","newsList":[{"id":"2454323132","title":"Xtl生物制药盘中异动 股价大跌8.39%报2.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454323132","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454323132?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:58","pubTimestamp":1722002281,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时58分，Xtl生物制药股票出现波动，股价快速下挫8.39%。截至发稿，该股报2.62美元/股，成交量618股，换手率0.01%，振幅12.24%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.32%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215801955da159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726215801955da159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2454909874","title":"Xtl生物制药盘中异动 急速下挫6.19%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454909874","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454909874?lang=zh_cn&edition=full","pubTime":"2024-07-25 22:07","pubTimestamp":1721916462,"startTime":"0","endTime":"0","summary":"北京时间2024年07月25日22时07分，Xtl生物制药股票出现异动，股价快速下跌6.19%。截至发稿，该股报2.78美元/股，成交量3261股，换手率0.06%，振幅1.01%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.82%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522074296820530&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072522074296820530&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2453252000","title":"Xtl生物制药盘中异动 早盘股价大涨5.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453252000","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453252000?lang=zh_cn&edition=full","pubTime":"2024-07-24 21:30","pubTimestamp":1721827838,"startTime":"0","endTime":"0","summary":"北京时间2024年07月24日21时30分，Xtl生物制药股票出现异动，股价快速拉升5.95%。截至发稿，该股报2.85美元/股，成交量4.3963万股，换手率0.81%，振幅4.46%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.00%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213038aefb3ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240724213038aefb3ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2453564350","title":"Xtl生物制药盘中异动 股价大跌7.60%报2.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453564350","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453564350?lang=zh_cn&edition=full","pubTime":"2024-07-23 22:58","pubTimestamp":1721746683,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日22时58分，Xtl生物制药股票出现波动，股价快速下跌7.60%。截至发稿，该股报2.53美元/股，成交量112股，换手率0.00%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.11%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232258039681f5e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232258039681f5e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2453799470","title":"Xtl生物制药盘中异动 早盘股价大涨5.06%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453799470","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453799470?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:37","pubTimestamp":1721659060,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时37分，Xtl生物制药股票出现异动，股价急速拉升5.06%。截至发稿，该股报2.70美元/股，成交量1.5414万股，换手率0.28%，振幅7.69%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.39%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722223740af9373e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722223740af9373e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2452477892","title":"Xtl生物制药盘中异动 早盘急速跳水6.18%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452477892","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452477892?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:26","pubTimestamp":1721399175,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日22时26分，Xtl生物制药股票出现波动，股价大幅下跌6.18%。截至发稿，该股报2.43美元/股，成交量932股，换手率0.02%，振幅0.77%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.41%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192226169681e90a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192226169681e90a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2452616804","title":"Xtl生物制药盘中异动 早盘股价大跌5.22%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452616804","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452616804?lang=zh_cn&edition=full","pubTime":"2024-07-17 22:29","pubTimestamp":1721226583,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日22时29分，Xtl生物制药股票出现异动，股价快速下跌5.22%。截至发稿，该股报2.54美元/股，成交量2572股，换手率0.05%，振幅0.28%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.57%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717222944af92cb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717222944af92cb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2452949360","title":"Xtl生物制药盘中异动 快速上涨5.38%报2.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452949360","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452949360?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:33","pubTimestamp":1721154836,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时33分，Xtl生物制药股票出现波动，股价快速上涨5.38%。截至发稿，该股报2.62美元/股，成交量1.5331万股，换手率0.28%，振幅3.21%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.11%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023356af929ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717023356af929ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2450539796","title":"Xtl生物制药盘中异动 早盘大幅下挫9.16%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450539796","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450539796?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:17","pubTimestamp":1720793861,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时17分，Xtl生物制药股票出现异动，股价大幅下挫9.16%。截至发稿，该股报2.43美元/股，成交量843股，换手率0.02%，振幅0.37%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为1.46%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122217419681c67a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407122217419681c67a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2450635033","title":"Xtl生物制药盘中异动 早盘快速跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450635033","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450635033?lang=zh_cn&edition=full","pubTime":"2024-07-11 21:31","pubTimestamp":1720704705,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日21时31分，Xtl生物制药股票出现异动，股价大幅下挫5.18%。截至发稿，该股报2.18美元/股，成交量164股，换手率0.00%，振幅0.00%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.09%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 是一种已知的贫血药物，正在开发中以延长晚期多发性骨髓瘤  患者的生存期。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112131459f34dfdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112131459f34dfdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2448568949","title":"Xtl生物制药股价重挫11.11% 市值跌62.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448568949","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448568949?lang=zh_cn&edition=full","pubTime":"2024-07-02 02:12","pubTimestamp":1719857556,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日02时12分，Xtl生物制药股票出现波动，股价急速跳水11.11%。截至发稿，该股报2.16美元/股，成交量1230股，换手率0.02%，振幅3.29%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.56%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702021236968187a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702021236968187a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2446403310","title":"Xtl生物制药盘中异动 临近收盘股价大跌5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446403310","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446403310?lang=zh_cn&edition=full","pubTime":"2024-06-27 03:40","pubTimestamp":1719430801,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日03时40分，Xtl生物制药股票出现波动，股价大幅下挫5.65%。截至发稿，该股报2.17美元/股，成交量530股，换手率0.01%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为1.10%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406270340019f68df7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406270340019f68df7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2444246303","title":"Xtl生物制药股价重挫12.10% 市值跌52.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444246303","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444246303?lang=zh_cn&edition=full","pubTime":"2024-06-20 23:21","pubTimestamp":1718896878,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日23时21分，Xtl生物制药股票出现波动，股价快速下跌12.10%。截至发稿，该股报2.18美元/股，成交量1.1677万股，换手率0.21%，振幅3.43%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.13%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062023212096815865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062023212096815865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2444433936","title":"Xtl生物制药盘中异动 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444433936","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444433936?lang=zh_cn&edition=full","pubTime":"2024-06-18 21:35","pubTimestamp":1718717713,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日21时35分，Xtl生物制药股票出现异动，股价大幅上涨5.73%。截至发稿，该股报2.58美元/股，成交量7561股，换手率0.14%，振幅0.01%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.11%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618213514aef578c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618213514aef578c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2444715167","title":"Xtl生物制药股价飙升18.63% 市值涨245.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444715167","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444715167?lang=zh_cn&edition=full","pubTime":"2024-06-17 21:31","pubTimestamp":1718631088,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日21时31分，Xtl生物制药股票出现异动，股价大幅上涨18.63%。截至发稿，该股报2.42美元/股，成交量4.7589万股，换手率0.87%，振幅3.43%。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Xtl生物制药涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Longeveron Inc.较为活跃，换手率分别为2104.32%、357.45%、57.34%，振幅较大的相关个股有Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.、Sellas Life Sciences Group, Inc.，振幅分别为17.69%、6.81%、6.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721312895b9dda3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061721312895b9dda3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2443670191","title":"Xtl生物制药盘中异动 股价大跌7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443670191","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443670191?lang=zh_cn&edition=full","pubTime":"2024-06-15 00:33","pubTimestamp":1718382798,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日00时33分，Xtl生物制药股票出现异动，股价快速跳水7.12%。截至发稿，该股报2.02美元/股，成交量2925股，换手率0.05%，振幅4.14%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.01%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003318968145a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615003318968145a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2443659289","title":"Xtl生物制药盘中异动 临近收盘股价大涨5.39%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443659289","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443659289?lang=zh_cn&edition=full","pubTime":"2024-06-13 04:16","pubTimestamp":1718223419,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日04时16分，Xtl生物制药股票出现异动，股价急速上涨5.39%。截至发稿，该股报2.15美元/股，成交量1.1869万股，换手率0.22%，振幅6.37%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.69%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613041659941ee244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613041659941ee244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2441067885","title":"Xtl生物制药盘中异动 快速下挫5.05%报2.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441067885","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441067885?lang=zh_cn&edition=full","pubTime":"2024-06-07 22:45","pubTimestamp":1717771539,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日22时45分，Xtl生物制药股票出现波动，股价大幅跳水5.05%。截至发稿，该股报2.24美元/股，成交量1537股，换手率0.03%，振幅8.05%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体跌幅为0.02%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607224539af8cabab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607224539af8cabab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0},{"id":"2441747202","title":"Xtl生物制药盘中异动 急速下跌5.60%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441747202","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441747202?lang=zh_cn&edition=full","pubTime":"2024-06-07 00:43","pubTimestamp":1717692230,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日00时43分，Xtl生物制药股票出现异动，股价急速下挫5.60%。截至发稿，该股报2.36美元/股，成交量2.0714万股，换手率0.38%，振幅5.60%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.43%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607004351aef3d591&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607004351aef3d591&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XTLB"],"gpt_icon":0},{"id":"2440365112","title":"Xtl生物制药盘中异动 早盘股价大跌5.47%报2.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440365112","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440365112?lang=zh_cn&edition=full","pubTime":"2024-06-04 21:54","pubTimestamp":1717509298,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日21时54分，Xtl生物制药股票出现异动，股价急速下挫5.47%。截至发稿，该股报2.42美元/股，成交量3254股，换手率0.06%，振幅0.00%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Xtl生物制药股票所在的生物技术行业中，整体涨幅为0.34%。Xtl生物制药公司简介：XTL Biopharmaceuticals Ltd 致力于开发治疗未满足医疗需求的疗法。rHuEPO 在临床实践中用于治疗各种贫血，包括肾病性贫血和癌症相关性贫血。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215458af8beefc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604215458af8beefc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XTLB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xtlbio.com","stockEarnings":[{"period":"1week","weight":0.1042},{"period":"1month","weight":0.2435},{"period":"3month","weight":0.1808},{"period":"6month","weight":2.247},{"period":"1year","weight":2.5138},{"period":"ytd","weight":1.8314}],"compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0118},{"period":"3month","weight":0.0593},{"period":"6month","weight":0.1046},{"period":"1year","weight":0.182},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xtl Biopharmaceuticals Ltd.在以色列国法律下于1993年3月9日依法成立。公司从事于药物产品的收购和研发，为了满足未得到满足的医疗需求。最近在致力于MM的治疗，精神分裂症和丙型肝炎。公司研究、研发和出售通过处理器治疗的非药用和非侵入性治疗多种疾病的家庭治疗设备。治疗的疾病例如有高血压、心力衰竭、失眠和精神紧张。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.120788},{"month":2,"riseRate":0.4,"avgChangeRate":-0.024778},{"month":3,"riseRate":0.4,"avgChangeRate":0.168776},{"month":4,"riseRate":0.4,"avgChangeRate":-0.03256},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.052628},{"month":6,"riseRate":0.5,"avgChangeRate":0.003823},{"month":7,"riseRate":0.4,"avgChangeRate":0.484211},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.031253},{"month":9,"riseRate":0.214286,"avgChangeRate":-0.074183},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018436},{"month":11,"riseRate":0.4,"avgChangeRate":-0.045684},{"month":12,"riseRate":0.2,"avgChangeRate":-0.058576}],"exchange":"NASDAQ","name":"Xtl生物制药","nameEN":"XTL Biopharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtl生物制药,XTLB,Xtl生物制药股票,Xtl生物制药股票老虎,Xtl生物制药股票老虎国际,Xtl生物制药行情,Xtl生物制药股票行情,Xtl生物制药股价,Xtl生物制药股市,Xtl生物制药股票价格,Xtl生物制药股票交易,Xtl生物制药股票购买,Xtl生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtl生物制药(XTLB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtl生物制药(XTLB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}